Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Feb 11;16(2):e0246808. doi: 10.1371/journal.pone.0246808

Spatial pattern of COVID-19 deaths and infections in small areas of Brazil

Everton Emanuel Campos de Lima 1, Ezra Gayawan 2, Emerson Augusto Baptista 3,*, Bernardo Lanza Queiroz 4
Editor: Albert Schriefer5
PMCID: PMC7877657  PMID: 33571268

Abstract

As of mid-August 2020, Brazil was the country with the second-highest number of cases and deaths by the COVID-19 pandemic, but with large regional and social differences. In this study, using data from the Brazilian Ministry of Health, we analyze the spatial patterns of infection and mortality from Covid-19 across small areas of Brazil. We apply spatial autoregressive Bayesian models and estimate the risks of infection and mortality, taking into account age, sex composition of the population and other variables that describe the health situation of the spatial units. We also perform a decomposition analysis to study how age composition impacts the differences in mortality and infection rates across regions. Our results indicate that death and infections are spatially distributed, forming clusters and hotspots, especially in the Northern Amazon, Northeast coast and Southeast of the country. The high mortality risk in the Southeast part of the country, where the major cities are located, can be explained by the high proportion of the elderly in the population. In the less developed areas of the North and Northeast, there are high rates of infection among young adults, people of lower socioeconomic status, and people without access to health care, resulting in more deaths.

Introduction

The COVID-19 pandemic has proved to be a challenge that is capable of impacting public health in all countries of the world with outcomes hitherto unimaginable. However, for several reasons, including political and economic reasons, some countries, like Brazil, have faced additional difficulties in controlling the pandemic. Brazil has become the new epicenter of this disease [1] as a result of the actions of many local authorities who disregarded WHO recommendations and did not implement strong measures such as population isolation, mask wearing, testing and contact tracing [24].

Brazil is characterized by large regional and socioeconomic disparities and high levels of inequality in access to health services. Thus, one may expect these features to impact the country’s number of infections and deaths from COVID-19 at different levels across regions of the country. Additionally, at the onset of the pandemic, there was a positive correlation between deaths and infections rates in a few cities in the southern part of the country [5], but recently, the disease has also spread through less developed areas of the country [69].

Besides health disparities, there are three components that need to be considered when studying the pattern of COVID-19 in Brazil. First, mortality rates are marked by a considerable age gradient, that is, the number of deaths is significantly higher among the elderly and, consequently, the population age structure is important for understanding the spread and the risk of mortality across areas [1012]. Second, the number of deaths is significantly higher among males [13]. We hypothesized that since women give more attention to issues affecting their health, this could have a positive impact on mortality risk. In addition, women are the majority of informal workers, domestic workers and the unemployed [14], that is, they are also more directly affected by the lockdown imposed in many parts of the country. Finally, as is the case elsewhere, pre-existing health problems or comorbidities seem to increase mortality risk in the population [12,15]. Some studies have shown that mortality is significantly higher in population strata that present any history of cardiovascular diseases, diabetes or obesity [12,16,17]. The combination of these three components–age structure, comorbidities and sex–may also play a role in the final number of deaths.

In this paper, we used publicly available data from the Brazilian Ministry of Health to estimate infection and mortality rates from COVID-19 in small-areas, taking into consideration the population age structure and sex distribution, and the level of income inequality across regions. We accounted for the number of intensive care units (ICUs) and number of physicians available in each municipality in order to consider the possible relationship with cases and deaths from COVID-19. We used a Bayesian hierarchical model for the 558 micro-regions of Brazil, based on data available at the end of July. Estimates at the local level are very important to develop proper public health interventions and evaluate the impact of the pandemic. An important caveat is that we used information on cumulative infections and death counts on a specific date. We did not control for the period in which the pandemic started in each area of the country, but we used the most recent data available to investigate how the pandemic has spread across the country. In addition, in using the cumulative count of cases and deaths in municipalities that had counts, we assumed that other municipalities had zero counts as of the date the first cases were recorded. This explains why, in the case of mortality, we used a zero-inflated Poisson model, since no death was recorded in many of the municipalities as at the time of the study. Notwithstanding, we observed that areas where the pandemic spread later went on to report significant increases and are rapidly catching-up, in terms of cases and mortality, to the areas that began to experience the pandemic first.

Methods

Data source and level of analysis

We use public available data from the Ministry of Health of Brazil, DATASUS, available at https://opendatasus.saude.gov.br/dataset/casos-nacionais [18]. Since 2009, there has been a system of surveillance for Serious Acute Respiratory Syndrome (SARS) that tracks influenza, SARS and other respiratory illnesses across the country. The system incorporates recent information on COVID-19 deaths and infections at the municipal level (defined as a single political boundary), the smallest geographical aggregation of the country. In addition, data on intensive care unit (ICUs) and number of physicians available in each municipality in 2019 were extracted from the Instituto Brasileiro de Geografia e Estatística (IBGE), which is also publicly available (https://mapasinterativos.ibge.gov.br/covid/saude/).

Noronha et al [19] show that the number of health care beds in Brazil is about half of what is observed in OECD countries. Moreover, the spatial distribution is very unequal across the country. According to their analysis, the regions with lowest supply are concentrated in Amazonas, Pará, Roraima, Minas Gerais and Ceará. The supply of ICUs is also very unequal across the country, with most of regions in the North and Northeast showing the lowest supply of tertiary care, which is highly concentrated in the state capitals.

Due to instability in the numbers of cases and the size of the exposed population, we aggregated the municipality information into 558 microregions, as defined by the Brazilian National Statistical Office (IBGE). These geographical areas are aggregated according to regional and socioeconomic similarities, which provide a good benchmark to compare spatial distribution of COVID-19 disease across the country.

We collected the information on July 20th, when Brazil had registered 77,226 deaths in this database and a total of 1,795,054 infections. There were 45,013 deaths of males and 32,213 of females–a male/female ratio of 1.39. For infections, there is a different picture, a male/female ratio of 0.89, with 846,744 and 948,310 infections for males and females, respectively.

Statistical method

We used a Bayesian formulation of a spatial autoregressive model (SAM), suitable for smoothing and stabilizing spatial estimates, to study the spatial pattern of the infections and mortality [20].

The observed count of cases Yi in area i is modelled using a Poisson distribution with mean Eiθi, where Ei is the expected count of cases and θi is the relative risk in area i. The relative risk (θi) quantifies whether an area has a higher (θi>1) or lower (θi<1) risk than the average risk in the standard population. In the case of mortality, because of the large number of zeros recorded in most of the study areas, a zero-inflated Poisson model was considered appropriate. If Yi~Po(Eiθi), i = 1,…n, then the relative risk (θi) can be modelled through a log link function such that

log(θi)=α+ui+vi+γi+f(icu)+f(phy) (1)

Where α is the overall risk in the study areas, (ui+vi) is an area random effect, such that ui models the spatial dependency between the relative risks and vi is an unstructured exchangeable component that models uncorrelated noise, such that viN(0,σv2), while γi is a function assumed for the age categories. The functions f(icu) and f(phy) are smooth functions assumed to model the possible nonlinear effects of number of ICUs and number of physicians. The structured spatial component was considered through the conditional autoregressive (CAR) distribution, which smooths the risks of certain neighbourhood structures, considering two areas neighbours if they share a common boundary. The prior is specified as:

(ui|ui)N(u¯δi,δu2nδi),

Where u¯δi=nδi1jδiuj, δi represents the set of neighbours and nδi is the number of neighbours of area i. The unstructured component vi was considered as independent and identically distributed normal with zero mean and variance δv2. The functions γi, f(icu), and f(phy) were modelled through a random walk of order 2 prior, and γi was also considered as a linear effect and modelled together with the intercept using Gaussian priors with mean 0 and precision 0.001.

The Bayesian inference was determined using the integrated nested Laplace approximation (INLA) [21], as implemented in the R-INLA package [22]. For each of cases and mortality we considered four models for each gender by varying the forms and terms in model 1 and compared model performance through the deviance information criterion (DIC) and Watanabe information criterion (WAIC), where the model with the lowest value for each of the criterion is considered the best. Results reported are based on the best model.

Decomposition of mortality and infection risk according to age structure

In addition to the spatial analysis, we performed a decomposition analysis to investigate the possible effects of population age structure on mortality and infections. Thus, we sought to analyze the contribution of this factor on possible regional differences in the risks of death and infection across the regions [23].

We decomposed each difference in mortality and infection risk between two regions based on Kitagawa’s [24] formulation:

R2R1=i=1n(P2iP1i)×(R2iR1i)2)+i=1n(R2iR1i)×(P2iP1i)2) (2)

Where, R2 and R1 are the overall risks of an outcome in populations 2 and 1, and i is the category of predictor variable, age. P2i and P1i are the proportion of population 2 and 1 in category i of the predictor, and R2i and R1i are the risks of the outcome in population 2 and 1 in category i of the predictor.

Results

Fig 1 presents the box plot of the posterior means of the relative risks of morality by age group from all the microregions. Mortality risks from COVID-19 are low in the age group 0–4 years but increase steadily with age. Though, on average, the relative risks for all the microregions are below one unit across the age groups, the Fig 1 reveals that from the 40–44 age group on, there are several regions standing as outliers, where the risks are above one, and this is more pronounced for individuals aged 80 years and above. These patterns of risks are observed for males and females, but mortality risks for males are greater than for females across all ages.

Fig 1. Log relative mortality risk according to conventional five-year age groups for both sexes in Brazil, 2020.

Fig 1

Source: Brazilian Ministry of Health 2020.

Fig 2 presents, for infection from COVID-19, the estimated effects for number of ICUs and number of physicians respectively, while Fig 3 presents the results for mortality. The Figs show the posterior mean estimates (middle solid lines) surrounded by the 95% credible intervals. For all the plots, the credible intervals become wider as the number of ICUs and physicians increase. This is because only few municipalities have large numbers of ICUs and physicians. As evident from the plots, the number of ICUs appears to have little or no effects on infection for both sexes, as the estimates are about zero. For number of physicians, the results show slight rise in infections as the number of physicians becomes greater than 3500, especially for males. In the case of mortality (Fig 3), the posterior mean estimates are about zero for both variables, indicating minimal effects on mortality from COVID-19 in the municipalities of Brazil.

Fig 2. Estimated effects of number of ICUs and number of physicians on infections from COVID-19 in the municipalities of Brazil.

Fig 2

Fig 3. Estimated effects of number of ICUs and number of physicians on mortality from COVID-19 in the municipalities of Brazil.

Fig 3

Figs 4 and 5 show the spatial distribution of the posterior means for relative risks for mortality and infection from COVID-19, respectively. The findings from the spatial analysis are not reported in the conventional 5-year age groups, but are instead in three large age groups (0–39, 40–59, and >60 years). We adopt these age ranges because our estimates show that the likelihood of death is quite small for individuals under 40 years of age, but increases slowly up to age 60 and then rises exponentially. Additionally, the age pattern of the relative risks of infection follows a structure different from those of mortality, peaking between the ages of 20–54 years old, a result similar to the findings of another study [13] (data not shown). To use the same scale of comparison for deaths and infections, we opted to present all spatial analyses using these age groups.

Fig 4. Spatial pattern of COVID-19 mortality risk by sex and microregion of Brazil, 2020.

Fig 4

Source: Brazilian Ministry of Health 2020.

Fig 5. Spatial pattern of COVID-19 infection risk by sex and microregion of Brazil, 2020.

Fig 5

Source: Brazilian Ministry of Health 2020.

In general, the results show that the relative risks for mortality (Fig 4) by microregion and sex are remarkably higher for older adults. Similar spatial patterns are observed for males and females. There are few distinctions in the geographical distribution of the risks of deaths between males and females across the age groups. From children to young adults, the relative risks almost do not surpass the value of 0.20 across the microregions. Between the ages of 40 and 59, there were isolated spots of high mortality risk, but in few places around the North Amazon Metropolitan area (Manaus) and in the Northeast coast microregion of Fortaleza (Ceará). These two areas were heavily affected in terms of cases and deaths in the first months of the pandemic [7,25].

Additionally, in the Rio de Janeiro and São Paulo microregions, located in the Southeast of Brazil, there are spatial clusters of high mortality risks among this age group. This could be expected because, being business and touristic areas, these two locations were the first to report cases of SARS-CoV-2 infection in the country [7,25]. Once more, it is important that we take into consideration the time that the pandemic hit a certain location, which may affect its relative risks in comparison with other locations. However, this fact does not entirely compromise our estimates because we also see many other areas in the country that registered much later cases of COVID-19 and they are showing relative mortality risks similar to those of the micro-regions that present more consolidated data.

For the population above 60 years of age, the results indicate additional spatial clusters. There exists a cluster of higher mortality risks that extends from the Southeast part of the country and connects to the Center-West of the country. In addition, North Amazon and the coast of the Northeast regions present a high risk of mortality for the elderly due to COVID-19. One interesting fact is that the highest mortality risks are basically located in Northern and Northeastern coast areas of Brazil, despite the South and Southeast microregions presenting older population age structures [26], and one would expect that in these last regions overall mortality due to COVID-19 might be higher, but this is not the case, especially in the aged South region of the country. We may speculate that socioeconomic disparities and limited access to health facilities in Northern parts of Brazil play a role in increasing mortality risks among elderly groups in these areas.

Using PNS data from 2013, Borges and Crespo [27] show that age is the principal risk factor for comorbidities associated with COVID-19 in Brazil, but sociodemographic variables also have important impacts, generally indicating higher risk for persons in more vulnerable categories, such as those with less schooling and the black and brown population. Their study also shows the prevalence of certain diseases such as diabetes and high blood pressure across different age groups and other SES categories.

A second important finding is that the spatial pattern of infection risks is also highly concentrated in the North and Northeast of Brazil (Fig 5). Here, we see a significant contribution of the young adult population to increasing the infection risk in these areas, while in other parts of the country the risk of COVID-19 infection is much lower. In addition to the socioeconomic dimension, the high infection risk in young adult population could explain the higher risk of mortality in these areas as well.

We now turn our analysis to the decomposition effects. Fig 6 shows the decomposition of the effects of mortality and infection risks in terms of differences in age compositions and other effects, captured by differences in risks. To facilitate the analyses, we grouped the microregions according to macroregions and selected the region with the highest proportion in the oldest age group (the South), as a benchmark of comparison with the others. This way, we were able to analyze how the age structure affects COVID-19 mortality and infections across the country.

Fig 6. Differences in mortality and infection risks decomposed by age composition and other effects, comparison between macroregions of Brazil, South versus other regions.

Fig 6

Source: Brazilian Ministry of Health 2020.

Population age structure across regions in Brazil is very different. The population is younger in the North and Northeast and older in the South and Southeast. In 2018, about 10% of the Brazilian population was over 65 years of age, but the variation between Federation Units can range from 13% in Rio Grande do Sul to 7% in Mato Grosso. We cannot directly compare mortality levels from one state and another because it can show the impact of both mortality levels and age structure.

The decomposition exercise did not show major differences among females and males, so we describe the findings for both sexes together. In terms of mortality risks, with the exception of the Center-West, the South region has a lower risk of mortality than the other regions. Age composition tends to reduce these differences, especially relative to the younger populations in the Northern and Northeastern regions, but other elements are responsible for increasing the differences in mortality risk between the South and other parts of Brazil.

When we looked at infection risks, age composition played a small role in the differences between macroregions. All areas presented a higher risk of COVID-19 infection than the South, and many unobserved factors are responsible for these regional differences in the number of cases. This last finding does not exclude the fact that age structure also played an important role in the spatial pattern of infection, as we saw in the previous estimates disaggregated by microregions.

The population is younger in many microregions of the North and Northeast, but in these regions, the highest overall mortality rates are presented, when we control for population age structure. We also found that these areas, even before the pandemic, presented greater risks of general mortality and did not have good health infrastructure [9,28].

Discussion

In most countries, we do not have only one COVID-19 outbreak going on. There are several differences across regions in the rhythm and stage of the outbreaks [29]. Thus, it is very relevant to investigate the patterns in infections and mortality across different regions of a socioeconomically diverse country like Brazil [30,31]. One important issue is the limitation regarding COVID-19 data in the country due to the lack of adequate testing and reporting. In this study, we use a Bayesian hierarchical model to estimate rates of infection and mortality from COVID-19 based on the microregions of Brazil, taking into account the population age structure and sex distribution, and controlling for the number of ICUs and physicians available to the municipalities as well as the levels of socioeconomic inequality commonly expressed in regional diversity.

Overall, our results suggest a different spatial pattern between the risks of death and the relative risks of infection for both sexes. While the relative mortality risks by microregion and sex are remarkably higher for older adults, particularly for men, the relative risks for infections are concentrated among young adults, being proportionally higher among women. However, mortality risks are much greater for males than females.

The number of ICUs and physicians appear to have only minimal impact on infection and death from COVID-19 in the municipalities of Brazil. A possible explanation for these unexpected findings could be that, in most cases, the number of these facilities is proportional to the population of the municipalities, such that crowded municipalities would have a higher number of ICUs and physicians. Noronha et al. [19] discuss the distance from each city to a main health care hub and show that regions in the North and Northeast have the longest distance to a city with an adequate offer of ICU beds. Also, Pereira et al. [32] show that there is a large variation in access to health care in Brazil. The access to ICUs varies across cities and regions and is much lower in poorer areas.

We find that almost all the regions in the North and a good number of the microregions in the Northeast coast appear to be at a disadvantage in terms of the overall risk of mortality, when compared to the Southeast and South regions of the country. These are important points to be considered when coping with COVID-19, a disease that is more severe in older populations. Even with a younger demographic, many locations in the North and Northeast have higher overall mortality rate, which could be due to worse health conditions overall. In addition, these areas also present a great number of infections. In spite of the protective factor of a more youthful population, the microregions of the North and Northeast of the country have higher mortality rates due to age for certain causes of death that can accentuate the risks of complications from COVID-19 [33,34].

For instance, Baptista and Queiroz [35] observed a rapid increase in mortality from cardiovascular diseases between 2001 and 2015 in the Northern and Northeast parts of the country, whereas in the South and Southeast they found a steady decline. Overall, they also show that in approximately 75% of Brazilian microregions, men have higher mortality rates than women. The North and Northeast regions are the least developed socioeconomically regions of the country and have mortality rates higher than the others. Previous studies show that less developed areas have seen the fastest rate of increase in mortality from cardiovascular diseases in recent years. Finally, diabetes mellitus affects mainly women. In approximately 78% of Brazilian micro-regions, mortality rates are higher for women than men. However, the spatial distribution suggests that, for males, this cause is more heterogeneous when analyzing the country as a whole. Spatial analysis also shows that, for both men and women, there is a concentration of high rates of mortality from diabetes in regions of the North and Northeast of the country.

The Northern and Northeastern regions are the least socioeconomically developed regions of the country and have higher mortality rates than the others. França et al. [34] also show that mortality rates and prevalence of diabetes are concentrated in this region of the country [26,36]. The population is younger in many microregions of the North and Northeast, but that is where the highest overall mortality rates are presented when we control for population age structure. We also found that these areas, even before the pandemic, presented greater risks of general mortality and did not have good health infrastructure [9,28].

This scenario, combined with the weakening of measures to deal with the pandemic, such as the measures indicated by the WHO, are elements that need to be considered in mitigating possible future short- and medium-term regional impacts of this pandemic. There are certain areas that, even before the pandemic, already presented greater risks of general mortality, due to lack of good healthcare infrastructure, a large share of the population that needs emergency assistance from the government, and elderly people with comorbidities who are not practicing social isolation, even at the moment of the greatest spread of the pandemic. Populations in these areas are exposed to greater risks of collapse in the healthcare system and can give rise to a considerable increase in the number of deaths from COVID-19 [9].

Data Availability

This data is public available at: https://opendatasus.saude.gov.br/dataset/casos-nacionais.

Funding Statement

Gayawan contribution was funded by the São Paulo Research Foundation (FAPESP) grant 268 2018/18649-7. Lima and Gayawan thank the University of Campinas Research Fund - 269 FAEPEX for support.

References

  • 1.Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases 2020; 20: 533–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lancet The. COVID-19 in Brazil: "So what?". The Lancet 2020; 395: 1461 10.1016/S0140-6736(20)31095-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Jorge DC, Rodrigues MS, Silva MS, et al. Assessing the nationwide impact of COVID-19 mitigation policies on the transmission rate of SARS-CoV-2 in Brazil. medRxiv 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dantas RCC, Campos PA, Rossi I, Ribas RM. Implications of social distancing in Brazil in the COVID-19 pandemic. Infection Control & Hospital Epidemiology 2020. 10.1017/ice.2020.210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Souza CDFd, Paiva JPSd, Leal TC, Silva LFd, Santos LG. Evolução espaçotemporal da letalidade por COVID-19 no Brasil, 2020. Jornal Brasileiro de Pneumologia 2020; 46: e20200208 10.36416/1806-3756/e20200208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Candido DS, Claro IM, Jesus JG, et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science 2020; eabd2161 10.1126/science.abd2161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lima E, Vilela E, Peralta A, et al. Exploring excess of deaths in the context of covid pandemic in selected countries of Latin America. OSF Preprints 2020. [Google Scholar]
  • 8.França EB, Ishitani LH, Teixeira RA, et al. Óbitos por COVID-19 no Brasil: quantos e quais estamos identificando? Revista Brasileira de Epidemiologia 2020; 23: e200053 10.1590/1980-549720200053 [DOI] [PubMed] [Google Scholar]
  • 9.Codeço CT, Villela D, Coelho F, et al. Estimativa de risco de espalhamento da COVID-19 no Brasil e o impacto no sistema de saúde e população por microrregião. 2020. [Google Scholar]
  • 10.Dowd JB, Andriano L, Brazel DM, et al. Demographic science aids in understanding the spread and fatality rates of COVID-19. Proceedings of the National Academy of Sciences 2020; 117: 9696–8. 10.1073/pnas.2004911117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Goldstein JR, Lee RD. Demographic perspectives on the mortality of COVID-19 and other epidemics. Proceedings of the National Academy of Sciences 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nepomuceno MR, Acosta E, Alburez-Gutierrez D, Aburto JM, Gagnon A, Turra CM. Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden. Proceedings of the National Academy of Sciences 2020; 117: 13881–3. 10.1073/pnas.2008760117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Baptista EA, Queiroz BL. Regional Covid-19 Mortality in Brazil by Age. SocArXiv 2020. [Google Scholar]
  • 14.Barbosa ALNdH Costa JS, Hecksher M. Mercado de trabalho e pandemia da Covid-19: ampliação de desigualdades já existentes? 2020. [cited 2020 21 August]; Available from: http://repositorio.ipea.gov.br/handle/11058/10186. [Google Scholar]
  • 15.Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging 2020; 12: 6049–57. 10.18632/aging.103000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jordan RE A. Who is most likely to be infected with SARS-CoV-2? The Lancet Infectious Diseases 2020; 20: p995–6. 10.1016/S1473-3099(20)30395-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shuchman M. Low- and middle-income countries face up to COVID-19. Nature Medicine 2020; 26. 10.1038/d41591-020-00020-2 [DOI] [PubMed] [Google Scholar]
  • 18.Ministry of Health. Sistema de Informações sobre Mortalidade (SIM). 2020. [cited 2020 23 July]; Available from: https://opendatasus.saude.gov.br/dataset/casos-nacionais. [Google Scholar]
  • 19.Noronha KVMS Guedes GR, Turra, et al. The COVID-19 pandemic in Brazil: analysis of supply and demand of hospital and ICU beds and mechanical ventilators under different scenarios. Cadernos de Saúde Pública 2020; 36: e00115320 10.1590/0102-311X00115320 [DOI] [PubMed] [Google Scholar]
  • 20.LeSage JP. Bayesian estimation of spatial autoregressive models. International Regional Science Review 1997; 20: 113–29. [Google Scholar]
  • 21.Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2009; 71: 319–92. [Google Scholar]
  • 22.Lindgren F, Rue H. Bayesian spatial modelling with R-INLA. Journal of Statistical Software 2015; 63: 1–25. [Google Scholar]
  • 23.Medfod A, Trias-Llimos S. Population age structure only partially explains the large number of COVID-19 deaths at the oldest ages. Demographic Research 2020; 43: 533–44. [Google Scholar]
  • 24.Kitagawa EM. Components of a difference between two rates. Journal of the American Statistical Association 1955; 50: 1168–94. [Google Scholar]
  • 25.Peixoto Pedro S., Marcondes Diego, Peixoto Cláudia, Oliva SM. Modeling future spread of infections via mobile geolocation data and population dynamics. An application to COVID-19 in Brazil. PLoS ONE 2020; 15: e0235732 10.1371/journal.pone.0235732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Queiroz BL, Freire FHM, Lima EEC, Gonzaga MR. O risco de mortalidade por microrregiões e o efeito da composição etária no contexto da Covid-19. 2020. [cited; Available from: https://demografiaufrn.net/2020/05/04/o-risco-de-mortalidade-por-microrregioes-e-o-efeito-da-composicao-etaria-no-contexto-da-covid-19/. [Google Scholar]
  • 27.Borges GM D CC. Demographic and socioeconomic characteristics of Brazilian adults and COVID-19: a risk group analysis based on the Brazilian National Health Survey, 2013. Cadernos de Saude Publica 2020; 36: e00141020. [DOI] [PubMed] [Google Scholar]
  • 28.de Souza CDF, Carmo RFd, Machado MF. The burden of COVID-19 in Brazil is greater in areas with high social deprivation. Journal of Travel Medicine; 27: taaa145 10.1093/jtm/taaa145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Franch-Pardo I, Napoletano BM, Rosete-Verges F, Billa L. Spatial analysis and GIS in the study of COVID-19. A review. Science of The Total Environment 2020; 739: 140033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mollalo A, Vahedi B, Rivera KM. GIS-based spatial modeling of COVID-19 incidence rate in the continental United States. Science of The Total Environment 2020; 728: 138884 10.1016/j.scitotenv.2020.138884 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Martines MR, Ferreira RV, Toppa RH, Assuncao L, Desjardins MR, Delmelle EM. Detecting space-time clusters of COVID-19 in Brazil: mortality, inequality, socioeconomic vulnerability, and the relative risk of the disease in Brazilian municipalities. medRxiv 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pereira RH, Braga CKV, Servo LM, et al. Geographic access to COVID-19 healthcare in Brazil using a balanced float catchment area approach. medRxiv 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Borges GM. Health transition in Brazil: regional variations and divergence/convergence in mortality. Cadernos de Saúde Pública 2017; 33: e00080316 10.1590/0102-311X00080316 [DOI] [PubMed] [Google Scholar]
  • 34.França EB, Passos VMdA, Malta DC, et al. Cause-specific mortality for 249 causes in Brazil and states during 1990–2015: a systematic analysis for the global burden of disease study 2015. Population Health Metrics 2017; 15 10.1186/s12963-017-0156-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Baptista EA, Queiroz BL. The relation between cardiovascular mortality and development. Demographic Research 2019; 41: 1437–52. [Google Scholar]
  • 36.Queiroz BL, Freire F, Lima E, Gonzaga MR, Baptista EA. Patterns of Geographic Variation of Mortality by Causes of Death for Small Areas in Brazil, 2010. In: Jivetti B, Hoque MN, editors. Population Change and Public Policy; 2020. [Google Scholar]

Decision Letter 0

Albert Schriefer

23 Oct 2020

PONE-D-20-27148

Spatial pattern of COVID-19 deaths and infections in small areas of Brazil

PLOS ONE

Dear Dr. Baptista,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please, make sure you address all points raised by the three reviewers in length, since two of them (reviewers two and three) raised relevant questions about the soundness of the study approach. Also, note that reviewer one made several language edits directly to the submitted document as well as comments and suggestions within comment balloons to the side of the edited text. Make sure you don't miss these comments in the revised paper. Since the methodological questions raised by reviewers two and three are related to the adequacy of the study design, proper addressment of those issues will be deeply taken into account in the final decision of a revised version of the manuscript.

Please submit your revised manuscript by Dec 07 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Albert Schriefer, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript

  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. Please note that according to our submission guidelines (http://journals.plos.org/plosone/s/submission-guidelines), outmoded terms and potentially stigmatizing labels should be changed to more current, acceptable terminology. For example: “access backwardness” should be changed to “access challenges” and so forth (as appropriate).

4.Thank you for stating the following in the Acknowledgments Section of your manuscript:

[Gayawan contribution was funded by the São Paulo Research Foundation (FAPESP) [grant

268 2018/18649-7] and Lima and Gayawan thank the University of Campinas Research Fund -

269 FAEPEX for support.]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 [The author(s) received no specific funding for this work00]

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5.We note that [Figure(s) 2 and 3] in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1.    You may seek permission from the original copyright holder of Figure(s) [2 and 3] to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper describes the geographic distribution of COVID-19 throughout Brazil, attributing non-homogeneity to demographics specifically age. Specific comments and edits to conform to standard North American English are included in the attached document.

Reviewer #2: The manuscript presents interesting findings. But it needs to include essential confounding variables in the spatial analysis. Regarding mortality, the essential variable in this spatial analysis is the access to intensive care beds. This may explain part of the higher mortality in the north and northeast, which has the lowest number of beds per 100k of the country. It is important in this spatial analysis to incorporate this variable, perhaps it is more important than the distribution by sex and age in these regions. Another variable that can impact mortality is the coverage of primary care and coverage of supplementary private health. In addition, the analysis has to adjust the 558 558 micro-regions for the moment of the first case and count the same first days for the different regions. Only in this way is it possible to verify regional differences in terms of mortality and infection risks.

Reviewer #3: I recommend (i) to make (indirect) standardization by agegroup in the different region to support the analysis comparing the microregions among the Brazilian regions, apparently they may be so different (example: North (Amazon) Region with SouthWest region). (ii) The primary sample unit used did not match with the terciary (i.e ITU bed) health care service provided in macro or microregion defined by Brazilian Health System (SUS) (iii) The authors did not adjust by co-morbidities, however the Brazilian MoH conducted national surveys about non communicable diseases, with data available to make adjust about these diseases; (iv) In other hand, there is available data regarding National health care survey (PNAS) about health services provided by microregion (or cities)...the analysis conducted did not support the conclusions.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Julio Croda

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-20-27148__PlosOne Brazil 9-2020 reviewer-1.docx

Decision Letter 1

Albert Schriefer

27 Jan 2021

Spatial pattern of COVID-19 deaths and infections in small areas of Brazil

PONE-D-20-27148R1

Dear Dr. Baptista,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Albert Schriefer, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: The majority of the comments were included in the manuscript. I believe that this manuscript will help to improve the discussion about an uncommon level related to Unified Health System in the Brazil.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: Yes: WILDO NAVEGANTES DE ARAUJO

Acceptance letter

Albert Schriefer

1 Feb 2021

PONE-D-20-27148R1

Spatial pattern of COVID-19 deaths and infections in small areas of Brazil

Dear Dr. Baptista:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Albert Schriefer

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PONE-D-20-27148__PlosOne Brazil 9-2020 reviewer-1.docx

    Attachment

    Submitted filename: PONE-D-20-27148R1 r2r.docx

    Data Availability Statement

    This data is public available at: https://opendatasus.saude.gov.br/dataset/casos-nacionais.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES